首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1566148

细胞分选市场规模、份额、成长分析，按技术、按产品/服务、按应用、按地区 - 产业预测，2024-2031

Cell Sorting Market Size, Share, Growth Analysis, By Technology, By Product and Services, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球细胞分选市场规模为2.6476亿美元，从2023年的2.8332亿美元增长到2031年的4.8717亿美元，在预测期内（2024-2031年）预计复合年增长率为7%。

由于癌症、干细胞、免疫学、药物发现等领域的研究倡议不断增加，全球细胞分选市场正在强劲成长。这种快速增长是由对了解细胞功能和疾病机制的日益增长的需求推动的，这对于标靶治疗的开发至关重要。细胞分选技术在诊断、个人化治疗和疾病管理中发挥重要作用。加上高速、高解析度串流细胞仪和创新分选演算法的进步，这些技术正在提高分选过程的效率、准确性和吞吐量。细胞成像和即时监测等功能的整合进一步推动了市场势头。儘管具有成长潜力，但该市场仍面临挑战，例如购买和维护细胞分选设备的高成本，这阻碍了其采用，特别是在资源有限的环境中。此外，细胞分选程序的复杂性需要熟练的操作员，而缺乏训练有素的人员是更广泛采用的障碍。此外，管理人体细胞使用的伦理和监管环境使营运框架变得复杂，并可能影响市场扩张。然而，由于持续的技术创新和在各个治疗领域的广泛应用，美国细胞分选市场预计在可预见的未来将保持稳定的复合年增长率。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Becton, Dickinson and Company
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Sony
Miltenyi Biotec GmbH
Thermo Fisher Scientific
Merck KGaA
Sysmex Partec GmbH
On-Chip Biotechnologies Co., Ltd.
Cytonome/St, LLC
Union Biometrica, Inc.
BioLegend
Cytek Biosciences
Microsaic Systems
Sartorius AG
Verity Software House
STEMCELL Technologies
Cytognos SL
NanoCellect Biomedical, Inc.
Oxford Nanopore Technologies

简介目录

Product Code: SQMIG35A2354

Global Cell Sorting Market size was valued at USD 264.76 million in 2022 and is poised to grow from USD 283.32 million in 2023 to USD 487.17 million by 2031, growing at a CAGR of 7% during the forecast period (2024-2031).

The global cell sorting market is witnessing robust growth driven by heightened research initiatives in cancer, stem cell, immunology, and drug discovery. This surge stems from the increasing need to comprehend cellular functions and disease mechanisms, essential for developing targeted therapies. A significant factor amplifying demand is the rising incidence of chronic and infectious diseases, where cell sorting technology plays a critical role in diagnosis, treatment personalization, and disease management. Coupled with advancements in high-speed, high-resolution flow cytometers and innovative sorting algorithms, these technologies are enhancing the efficiency, accuracy, and throughput of sorting processes. The integration of features like cell imaging and real-time monitoring is further propelling market momentum. Despite its growth potential, the market faces challenges, including the high costs associated with purchasing and maintaining cell sorting equipment, which can impede adoption, particularly in resource-limited environments. Additionally, the complexity of cell sorting procedures necessitates skilled operators, and the scarcity of trained personnel poses a barrier to wider implementation. Furthermore, the ethical and regulatory landscape governing the use of human cells complicates the operational framework, potentially impacting market expansion. However, the U.S. cell sorting market is positioned to sustain a steady CAGR in the coming forecast period, driven by continuous innovation and increasing applications in various therapeutic areas.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Sorting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Sorting Market Segmental Analysis

Global Cell Sorting Market is segmented by Technology, Product and Services, Application, End User, and Region. Based on Technology, the market is segmented into Fluorescence-Based Droplet Cell Sorting (Jet-In-Air Cell Sorting, Cuvette-Based Cell Sorting), Magnetic-Activated Cell Sorting (MACS), Micro-Electromechanical Systems (MEMS) - Microfluidics. Based on Product and Services, the market is segmented into Cell Sorters (High-Range Cell Sorters (Priced Above USD 300,000), Mid-Range Cell Sorters (Priced Between USD 200,000-USD 300,000), Low-Range Cell Sorters (Priced Below USD 200,000)), Cell Sorting Reagents And Consumables, Cell Sorting Services. Based on Application, the market is segmented into Research Applications (Immunology & Cancer Research, Stem Cell Research, Drug Discovery, Other Research Applications), Clinical Applications. Based on End User, the market is segmented into Research Institutions, Medical Schools And Academic Institutions, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Testing Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Sorting Market

The global cell sorting market is significantly driven by the increasing incidence of chronic diseases, including cancer, immunological disorders, and cardiovascular conditions. These diseases necessitate advanced diagnostic and therapeutic solutions, wherein cell sorting technologies play a vital role by enabling precise characterization and isolation of specific cell populations. This precision is critical for effective disease diagnosis, monitoring patient responses, and developing personalized treatment strategies. As healthcare systems worldwide prioritize improved patient outcomes and tailored therapies, the demand for sophisticated cell sorting techniques will continue to escalate, propelling the market's growth and innovation in cell-based research and therapeutic applications.

Restraints in the Global Cell Sorting Market

The Global Cell Sorting market faces a significant restraint due to the critical shortage of trained professionals equipped with the necessary skills and expertise to operate complex cell sorting technologies effectively. This scarcity not only impedes market growth but also poses challenges in data analysis and interpretation, which are crucial for achieving accurate and reliable results. As cell sorting techniques require specialized training to navigate their intricate methodologies, the inability to adequately train and retain skilled personnel may lead to slower adoption rates and limited utilization of these advanced technologies, ultimately constraining the market's development potential.

Market Trends of the Global Cell Sorting Market

The Global Cell Sorting market is witnessing a significant shift towards microfluidic-based cell sorting technologies, which are rapidly gaining traction due to their innovative approach to cell manipulation. By leveraging microscale channels, these systems enhance sorting accuracy and efficiency while minimizing sample and reagent usage. This trend is propelled by the increasing demand for precise sorting of rare cell types and the convenience offered by the compact, portable nature of microfluidic devices, making them ideal for point-of-care applications. As research and clinical needs evolve, microfluidic cell sorting is poised to dominate the market, driving advancements in diagnostics and therapeutics.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Regulatory Landscape
Patent Analysis

Cell Sorting Market, by Technology

Market Overview
Fluorescence-Based Droplet Cell Sorting
- Jet-In-Air Cell Sorting
- Cuvette-Based Cell Sorting
Magnetic-Activated Cell Sorting (MACS)
Micro-Electromechanical Systems (MEMS) - Microfluidics

Cell Sorting Market, by Product & Service

Market Overview
Cell Sorters
- High-Range Cell Sorters (Priced Above USD 300,000)
- Mid-Range Cell Sorters (Priced Between USD 200,000-USD 300,000)
- Low-Range Cell Sorters (Priced Below USD 200,000)
Cell Sorting Reagents And Consumables
Cell Sorting Services

Cell Sorting Market, by Application

Market Overview
Research Applications
- Immunology & Cancer Research
- Stem Cell Research
- Drug Discovery
- Other Research Applications
Clinical Applications

Cell Sorting Market, by End User

Market Overview
Research Institutions
Medical Schools And Academic Institutions
Pharmaceutical And Biotechnology Companies
Hospitals And Clinical Testing Laboratories

Cell Sorting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Partec GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
On-Chip Biotechnologies Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytonome/St, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Union Biometrica, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLegend
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytek Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microsaic Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Verity Software House
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytognos S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoCellect Biomedical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments